Question 1

What is Acousia Therapeutics?

Accepted Answer

Acousia Therapeutics is a Entity.

Question 2

How often does Acousia Therapeutics appear in global news?

Accepted Answer

Tracked across 1 news events drawn from 6 articles.

Question 3

When was Acousia Therapeutics first tracked by Ergen?

Accepted Answer

First tracked on Jun 12, 2026.

Question 4

When was Acousia Therapeutics last mentioned in news?

Accepted Answer

Last active on Jun 12, 2026.

Question 5

What is Acousia Therapeutics's current news sentiment?

Accepted Answer

Aggregate sentiment score: 75 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

Question 6

How prominent is Acousia Therapeutics in global news coverage?

Accepted Answer

Attention score of 6, derived from article volume and coverage intensity across 1 events.

Question 7

What is the most recent event involving Acousia Therapeutics?

Accepted Answer

Acousia Therapeutics ACOU085 Phase 2a Results (Jun 12, 2026, 6 articles).

Question 8

How did the "Acousia Therapeutics ACOU085 Phase 2a Results" event impact Acousia Therapeutics?

Accepted Answer

Acousia Therapeutics GmbH announced positive top-line efficacy results from its Phase 2a PROHEAR Study for ACOU085, which could lead to further clinical development and potential collaborations.

Question 9

How is this data collected?

Accepted Answer

Ergen aggregates thousands of global news sources and extracts structured events, entities, and relationships with sentiment and attention metrics. Pages are daily static snapshots from the platform's live database.